جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

2 مُخرَج نتائج البحث عن «In vitro»

نسخة أوليةمفتوح (مستودع)2025

Molecular Docking, Dynamics Simulation, ADMET Profiling and DFT Reveal Anti-HCV Properties of Newly Discovered Catenulopyrizomicin A and B

Research Square

Abstract Background The hepatitis C virus (HCV) has no vaccine, and available medications present with adverse outcomes. A recent study reported potential anti-virus activity for the newly discovered catenulopyrizomicin A and B using non-in silico methods. Method In this study, the anti-HCV potential of catenulopyrizomicin A and B were evaluated using in silico approaches (molecular docking, simulation, ADMET profiling, and DFT) using ribavirin as a control and 5EQS as the target protein (NS3/4A). Results Docking scores for the ligands were − 5.8, -5.8, and − 6.1 kcal/mol, respectively, for catenulopyrizomicin B, ribavirin, and catenulopyrizomicin A. Two dimensional (2D) visualisation of the formed complexes revealed the dominance of Van der Waals forces and polar interactions between the ligands and the target protein. Docking simulations revealed variations in the simulation parameters (RMSD and RMSF) that indicated that the formed stables complexes (less than 2.0 Å), and this was further supported by low RMSF values that were less than 2.0 Å throughout the docking simulation runs. ADMET properties revealed that catenulopyrizomicin A and B had better intestinal absorption rates (36.41% and 36.28%) than ribavirin (30.95%), as well as good distribution, as revealed by their better VDss values (-0.53 to -0.61 for catenulopyrizomicin A and B) compared to ribavirin which was − 0.22. The DFT results showed that catenulopyrizomicin A and B are more reactive and nucleophilic than ribavirin. Conclusion Overall, the study showed that catenulopyrizomicin A and B possess potential anti-HCV properties that require further in vivo and in vitro evaluations.

hepatitis C virusanti-HCV activityNS3/4A proteaseribavirin
نسخة أوليةمفتوح (مستودع)2023

Rapamycin Induced Autophagy in Mesenchymal Stem Cells Modulates Cell Survival After Transplantation in a Rat Model with Cisplatin-Induced Ovarian Toxicity via Deactivation of the mTOR Pathway

Preprints.org

Purpose: We aimed to evaluate the impact of preconditioning adipose-derived mesenchymal stem cells (ADMSCs) with the autophagy inducer rapamycin (Rapa) on Cisplatin (Cis) induced ovarian toxicity in a rat model. Methods: ADMSCs were pretreated with 50 nmol/L rapa for two h in vitro. Another in vivo study included 96 female Sprague-Dawley rats divided into four equal groups: control, Cis, Cis +ADMSCs, and Cis +ADMSCs + Rapa. Rats were sacrificed after 2 and 6 weeks. Each group was subdivided into two equal subgroups: 6 rats were sacrificed to study ovarian parameters, and six were left for mating to evaluate the fertility index. Results: Autophagy activation was detected in ADMSCs + Rapa by increasing autophagosomes, high autophagy-specific LC3-II gene and protein expression, and low expression of p62 and mTOR genes. Moreover, transplantation of ADMSCs + Rapa restored balance between E2, FSH, and LH, increased antioxidant activity, and improved follicular count and quality after 2 and 6 weeks of treatment. Fertility index analysis manifested restoring reproductive capacity in the ADMSCs+ Rapa group at both intervals. Conclusions: Autophagy induction could enhance the therapeutic capability of ADMSCs by deactivating the mTOR pathway, which in turn promotes the ovarian folliculogenesis process after exposure to Cis.

rapamycinautophagyadipose-derived stem cellsmTOR signaling